THE WAITING GAME

A VIRTUAL QUEUE is forming outside virologists’ doors. People with hepatitis C are anxiously awaiting access to two new antiviral drugs, Vertex Pharmaceuticals’ telaprevir and Merck & Co.’s bocepre...